Dr Ivan Petyaev, CEO of Lycotec, a Cambridge based biotech company has received the Honoured Award at the 2nd World Conference on Targeting Liver Disease. The award was given for his pioneering oral-delivery Lysosome technology at the conference which was held in Malta last week, June 25th – 26th 2015.
Dr Petyaev, the inventor of the technology, commented:
‘’I was surprised and delighted that world leaders in hepatology recognised the quality of this development and the potential value of our innovation‘’
Malta Liver Conference 2015 provides a unique opportunity for interactions between industry and liver disease experts. Seeking to help identify unmet needs in hepatology, the 2 days conference looked towards the future to determine how to address the long-term challenges that hepatologists are likely to face in the coming years.